Oral miltefosine for the treatment of Indian visceral leishmaniasis

Transactions of the Royal Society of Tropical Medicine and Hygiene

Volumn 100, Issue SUPPL. 1, 2006, Pages

  Sundar, Shyam ^a   Jha, T K ^b   Thakur, C P ^c   Bhattacharya, S K ^d   Rai, M ^a  

^a BANARAS HINDU UNIVERSITY   (India)

^b Kala azar Research Center   (India)

^c Balaji Utthan Sansthan   (India)

^d RAJENDRA MEMORIAL RESEARCH INSTITUTE OF MEDICAL SCIENCES   (India)

Author keywords

India; Kala azar; Miltefosine; Visceral leishmaniasis

Indexed keywords

ALLOPURINOL; AMINOTRANSFERASE; AMPHOTERICIN B; ANTILEISHMANIAL AGENT; ANTIMONY; ATOVAQUONE; FLUCONAZOLE; KETOCONAZOLE; MILTEFOSINE; PENTAMIDINE; STIBOGLUCONATE SODIUM; TRIAZOLE DERIVATIVE;

ANTIPROTOZOAL ACTIVITY; ARTHRITIS; ARTICLE; CHILD CARE; CLINICAL OBSERVATION; CLINICAL TRIAL; DIARRHEA; DRUG APPROVAL; DRUG DOSE REGIMEN; DRUG EFFICACY; DRUG ERUPTION; DRUG HYPERSENSITIVITY; DRUG SAFETY; DRUG TOLERABILITY; EPISTAXIS; EYE TOXICITY; FETUS MALFORMATION; FEVER; GASTROINTESTINAL SYMPTOM; HEALTH CARE ORGANIZATION; HEMORRHOID HEMORRHAGE; HUMAN; HYPERBILIRUBINEMIA; INDIA; INSULIN DEPENDENT DIABETES MELLITUS; KIDNEY DISEASE; KIDNEY DYSFUNCTION; KIDNEY FAILURE; LEISHMANIA DONOVANI; LIVER DYSFUNCTION; NONHUMAN; PILOT STUDY; QUANTITATIVE ANALYSIS; RETINA DISEASE; SKIN METASTASIS; SOLID TUMOR; STEVENS JOHNSON SYNDROME; TERATOGENICITY; THROMBOCYTOPENIA; TREATMENT OUTCOME; UREMIA; VISCERAL LEISHMANIASIS; VOMITING;

ADMINISTRATION, ORAL; ADULT; ANTIPROTOZOAL AGENTS; CHILD; CLINICAL TRIALS; CLINICAL TRIALS AS TOPIC; HUMANS; INDIA; LEISHMANIASIS, VISCERAL; MULTICENTER STUDIES; MULTICENTER STUDIES AS TOPIC; PHOSPHORYLCHOLINE; PILOT PROJECTS; TREATMENT OUTCOME;

NASO HEXACANTHUS;

EID: 33749363878     PISSN: 00359203     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.trstmh.2006.02.011     Document Type: Article

References (22)

1. Berman J.D. Human leishmaniasis: clinical, diagnostic, and chemotherapeutic developments in the last 10 years. Clin. Infect. Dis. 24 (1997) 684-703
2. Bhattacharya S.K., Jha T.K., Sundar S., Thakur C.P., Engel J., Sindermann H., Junge K., Karbwang J., Bryceson A.D., and Berman J.D. Efficacy and tolerability of miltefosine for childhood visceral leishmaniasis in India. Clin. Infect. Dis. 38 (2004) 217-221
3. Croft S.I., Neal R.A., Pendergast W., and Chan J.H. The activity of alkyl phosphorylcholines and related derivatives against Leishmania donovani. Biochem. Pharmacol. 36 (1987) 2633-2636
4. Dummer R., Krasovec M., Roger J., Sindermann H., and Burg G. Topical administration of hexadecylphosphocholine in patients with cutaneous lymphomas: results of a phase I/II study. J. Am. Acad. Dermatol. 29 (1993) 963-970
5. Jha S.N., Singh N.K., and Jha T.K. Changing response to diamidine compounds in cases of kala-azar unresponsive to antimonial. J. Assoc. Physicians India 39 (1991) 314-316
6. Jha T.K., Sundar S., Thakur C.P., Bachmann P., Karbwang J., Fischer C., Voss A., and Berman J. Miltefosine, an oral agent, for the treatment of Indian visceral leishmaniasis. N. Engl. J. Med. 341 (1999) 1795-1800
7. Kuhlencord A., Maniera T., Eibl H., and Unger C. Hexadecylphosphocholine: oral treatment of visceral leishmaniasis in mice. Antimicrob. Agents Chemother. 36 (1992) 1630-1634
8. Mishra M., Biswas U.K., Jha A.M., and Khan A.B. Amphotericin versus sodium stibogluconate in first-line treatment of Indian kala-azar. Lancet 344 (1994) 1599-1600
9. Sundar S., Rosenkaimer F., Makharia M.K., Goyal A.K., Mandal A.K., Voss A., Hilgard P., and Murray H.W. Trial of oral miltefosine for visceral leishmaniasis. Lancet 352 (1998) 1821-1823
10. Sundar S., Gupta L.B., Makharia M.K., Singh M.K., Voss A., Rosenkaimer F., Engel J., and Murray H.W. Oral treatment of visceral leishmaniasis with miltefosine. Ann. Trop. Med. Parasitol. 93 (1999) 589-597
11. Sundar S., More D.K., Singh M.K., Singh V.P., Sharma S., Makharia A., Kumar P.C., and Murray H.W. Failure of pentavalent antimony in visceral leishmaniasis in India: report from the center of the Indian epidemic. Clin. Infect. Dis. 31 (2000) 1104-1107
12. Sundar S., Makharia A., More D.K., Agrawal G., Voss A., Fischer C., Bachmann P., and Murray H.W. Short-course of oral miltefosine for treatment of visceral leishmaniasis. Clin. Infect. Dis. 31 (2000) 1110-1113
13. Sundar S., Jha T.K., Thakur C.P., Engel J., Sindermann H., Fischer C., Junge K., Bryceson A., and Berman J. Oral miltefosine for Indian visceral leishmaniasis. N. Engl. J. Med. 347 (2002) 1739-1746
14. Sundar S., Jha T.K., Sindermann H., Junge K., Bachmann P., and Berman J. Oral miltefosine treatment in children with mild to moderate Indian visceral leishmaniasis. Pediatr. Infect. Dis. J. 22 (2003) 434-438
15. Thakur C.P., and Narayan S. A comparative evaluation of amphotericin B and sodium antimony gluconate, as first-line drugs in the treatment of Indian visceral leishmaniasis. Ann. Trop. Med. Parasitol. 98 (2004) 129-138
16. Thakur C.P., Kumar M., Singh S.K., Sharma D., Prasad U.S., Singh R.S., Dhawan P.S., and Achari V. Comparison of regimens of treatment with sodium stibogluconate in kala-azar. Br. Med. J. 288 (1984) 895-897
17. Thakur C.P., Kumar M., Kumar P., Mishra B.N., and Pandey A.K. Rationalisation of regimens of treatment of kala-azar with sodium stibogluconate in India: a randomised study. Br. Med. J. 296 (1988) 1557-1561
18. Thakur C.P., Kumar M., and Pandey A.K. Comparison of regimes of treatment of antimony-resistant kala-azar patients: a randomized study. Am. J. Trop. Med. Hyg. 45 (1991) 435-441
19. Thakur C.P., Kumar M., and Pandey A.K. Evaluation of efficacy of longer durations of therapy of fresh cases of kala-azar with sodium stibogluconate. Indian J. Med. Res. 93 (1991) 103-110
20. Thakur C.P., Sinha G.P., Sharma V., Pandey A.K., Kumar M., and Verma B.B. Evaluation of amphotericin B as a first line drug in comparison to sodium stibogluconate in the treatment of fresh cases of kala-azar. Indian J. Med. Res. 97 (1993) 170-175
21. Theischen M., Bornfeld N., Becher R., Kellner U., and Wessing A. Hexadecylphosphocholine may produce reversible functional defects of the retinal pigment epithelium. Ger. J. Ophthalmol. 2 (1993) 113-115
22. Verweij J., Planting A., van der Burg M., and Stoter G. A dose-finding study of miltefosine (hexadecylphosphocholine) in patients with metastatic solid tumours. J. Cancer Res. Clin. Oncol. 118 (1992) 606-608